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ABSTRACT                                                                                                                                                                                                    
A novel antibiotic resistant mechanism among biofilms is glucan-mediated sequestration in which ndvB gene 
encodes a glucosyltransferase involved in the formation of this glucans.  We studied the biofilm formation and 
antibiotic susceptibility pattern of  P. aeruginosa isolated from clinical samples, and measured the expression of 
ndvB gene among biofilm forming isolates and their planktonic counterparts. The study was conducted on 92 P. 
aeruginosa isolates. Biofilm was measured using tissue culture plate method. Antibiotic susceptibility of biofilm 
positive isolates and planktonic counterparts for ciprofloxacin, tobramycin and gentamycin was tested using tube 
microdilution method. Expression of ndvB gene was measured using Syper green real time PCR. We found that 44 
isolates (47.8%) of P. aeruginosa were biofilm positive. The biofilm formation was high among urine, 
endotracheal tube aspirate and burn isolates compared to isolates of wound specimens, with statistically non-
significant differences. None of biofilm forming isolates was susceptible to the 3 antibiotics compared to the 
presence of susceptible isolates among the planktonic counterpart (18/40.9% for ciprofloxacin, 12/27.3% for 
tobramycin and 13/29.5% for gentamycin). Expression of ndvB gene was significantly high in biofilm isolates  
than their corresponding counterpart, with significant correlations with minimal biofilm inhibitory concentration 
(MBIC) values of   cibrofloxacin (r=+ 0.65, p ), tobramycin (r= + 0.54 p  ) and gentamycin (r=+ 0.77, 
p   ).From this study we concluded that biofilm formation is an important character of P. aeruginosa that is 
a main cause of antibiotic resistance especially in isolates from catheterized urine , wound and endotracheal tube 
aspirate. NdvB gene expression is a mechanism of resistance to antibiotics in P. aeruginosa biofilms. 
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RESUME                                                                                                                                                                        
Un mécanisme de résistance aux antibiotiques chez les nouveaux films biologiques est glucane médiation par 
séquestration dans laquelle le gène codant pour la glycosyltransferase ndvB impliqués dans la formation de ces 
glucanes. Nous avons étudié la formation des biofilms et le profil de la sensibilité de P.aeruginosa aux 
antibiotiques isolé d’échantillons clinique et on a mesuré l’expression de gène de ndvB parmi les isolats qui 
forment les biofilms et leurs homologues planctoniques. L’étude a été menée sur 92isolats de P.aeruginosa. 
Biofilm a été mesuré en utilisant la méthode du tissu plaque de culture. Sensibilité aux antibiotiques des 
biofilms isolats positifs et homologues planctoniques pour la ciprofloxacine, la tobramycine, et la gentamycine a 
été teste en utilisant la méthode tube de micro dilution. L’expression de ndvB a été mesurée en utilisant la PCR en 
temps réel vert super. Nous avons trouvé que 44 isolats  (47.8%) de P.aeruginosaétaient biofilm positifs. La 
formation de biofilm était élevé parmi les urines, sonde endotrachéale aspirée, et isolats brulure par rapport aux 
isolats de spécimens 
de plaies avec des différences statistiquement non – significatives. Aucun des isolats formant des biofilms était 
sensible aux trois antibiotiques par rapport à la présence des isolats sensibles parmi les homologues 
planctoniques (18/40,9%pour ciprofloxacine, 12/27,3% pour tobramycine et 13/29,5% pour gentamycine). 
L’expression de gène de ndvB était significativement plus élevée chez les isolats biofilm que leurs homologues 
correspondants, avec des corrélations significatives avec un minimum biofilm concentration inhibitrice (CMI) des 
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valeurs de ciprofloxacine (r= + 0,65,  p<0,05      ), tobramycine (r= + 0,54   p<0,05   ) et gentamycine (r= + 0,77           p 
< 0,001  ). De cette étude nous avons conclu que la formation des biofilms est un caractère important de p. 
aeruginosa qui est une cause principale de la résistance aux antibiotiques en particulier dans les isolats provenant 
de l’urine cathétérisées, plaie et sonde endotrachéaleaspirée. L’expressiondugène dendvBest un mécanisme de 
résistance antibiotique chez biofilms de P.aeruginosa.                                                                                                                                                                        
Mots clés : P.aeruginosa, biofilms, résistance aux antibiotiques, etgène de ndvB.
INTRODUCTION                                                                                                    
Pseudomonas aeruginosa is a key opportunistic 
pathogen characterized by high-level antibiotic 
resistance and biofilm formation (1).Biofilm is a 
structured community of bacterial cells 
enclosed in a self-produced polymeric matrix 
adherent to an inert or living surface. Biofilm-
producing organisms are more antimicrobial 
resistant than organisms without biofilm. In 
some extreme cases, the concentrations of 
antimicrobials required to kill biofilm positive  
organisms can be three- to four-fold higher 
than for biofilm negative bacteria, depending 
on the species and drug combination (2). 
Biofilms have great importance for public 
health as they   are the main cause of 
nosocomial infections, especially implant-based 
and chronic infections (3). 
Antibiotic resistance in biofilms is due to a 
combination of many factors that act together 
to result in a level of resistance that is much 
higher  than that of planktonic bacteria (4,5). 
One factor of these is the altered expression of 
specific genes involved in the biofilm. Some of 
these genes may function to protect biofilm 
cells from antibiotics. NdvB gene, encodes the 
glucosyltransferase enzyme that responsible 
for the formation of cyclic glucans (6). The 
glucans are cyclic polymers of 12 to 15 β- (1 → 
3) -linked glucose molecules with 
phosphoglycerol substitutions (7). Inactivation 
of ndvB gene blocked glucan synthesis without 
affect the kinetics of biofilm formation, the 
architecture of the biofilms or growth of 
bacteria  (6). However, ndvB mutants of PA14 
strains exhibited increased sensitivity to the 
aminoglycosides tobramycin and gentamicin 
and the fluoroquinolone ciprofloxacin (6,7). 
This study aimed to detect the biofilm 
formation and antibiotic susceptibility pattern 
of Pseudomonas aeruginosa strains isolated from 
clinical samples, and to measure the expression 
of ndvB gene among biofilm forming isolates. 
MATERIALS AND METHODS 
Bacterial strains                                                      
They were isolated from patients hospitalized 
in surgery , burn units, and intensive care unit, 
at Zagazig University Hospitals, during the 
period from February 2015 –August 2015. 
Isolates were obtained from 274 specimens 
including catheterized urine, endotracheal tube 
aspirates (ETAs) and exudates of burn and 
septic wound. The specimens were analysed in 
the Lab. of Microbiology& Immunology 
Department, Zagazig University Hospitals .The 
isolates were identified as P. aeruoginosa by API 
20NE and stored at -70°C. The study was 
approved after receiving permission from 
Zagazig University Ehical Committee and a 
written consent was taken from each patient or 
his relative.  
Quantitation of biofilm 
It was done by tissue culture plate method as 
described previously (8) using sterile 96 well-
flat bottom polystyrene tissue culture plate 
with a lid (Sigma, USA). Methicillin –sensitive 
staphylococcus aureus ( MSSA) ATCC-25923 and 
P. aeruginosa ATCC-27853 were used as 
negative and positive control organisms , 
respectively (9). Sterile broth was inoculated in 
negative control wells. The absorbance at 570 
nm was determined using Microtiter plate 
reader (Spectra III, SIT measurement, 
Australia). All samples were tested in triplicate 
and the results were averaged. The 
interpretation for biofilm production was done 
according to specific criteria (10). 
Antibiotic susceptibility testing 
Antimicrobial agents 
They included gentamycin, tobramycin and 
ciprofloxacin, provided as standard powder 
from Sigma Company, USA,. Antibiotics were 
serially diluted in cation- adjusted Muller 
Hinton broth (CAMHB) according to Clinical 
Laboratory Standard Institute (CLSI) (11).  
Biofilm susceptibility assay                                       
It was performed as previously described (12) 
with certain modifications to make the 
procedure compatible with our clinical 
microbiology laboratory.  Biofilm positive 
strains were subcutured twice on tryptic soy 
agar (TSA, Oxoid) with 5% sheep blood after 
retrieval from -70°C storage and then gown 
overnight in CAMHB. After dilution of this 
culture to 0.5 McFarland, 100 µl was 
transferred to all except the well No 12 of a 
round-bottom 96-well microtiter plate with a 
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lid (Sigma, USA) followed by incubation at 
37°C for 20-24 h with no movement. After 
incubation, the microtiter plate was rinsed by 
sterile distilled water and 100 µl of CAMHB  
with serial two fold dilutions of antibiotics (512 
- 1µg/ml for gentamycin and tobramycin and 
128 - 0.25µg/ml for ciprofloxacin) were added 
to corresponding wells from 1-10 in each row. 
In each row, well No 11 was used as growth 
control while well No 12 was used as sterility 
control. Each row represents an antibiotic 
susceptibility test of one antibiotic against one 
isolate of the organism. The plate was 
incubated at 37°C for 20-24 h. After antibiotic 
incubation, the microtiter plate was again 
rinsed three times in sterile water then 100 µl 
antibiotic-free CAMHB was added to each 
well. Each plate was sonicated at room 
temperature for 5 min The optical density at 
650 nm (OD650) was measured on microtiter 
plate reader before and after incubation at 37°C 
for 6 h. Adequate biofilm growth for growth 
control wells was defined as a mean OD650 
difference that is ≥0.05.  The biofilm inhibitory 
concentration (MBIC) was the lowest 
concentration of antibiotic that resulted in an 
OD650 difference ≤ 10% of the mean of two 
readings of growth control wells (12). 
Planktonic susceptibility assay                              
Conventional minimum inhibitory 
concentration, MIC, of the planktonic bacterial 
population was measured using standard broth 
microdilution method according to CLSI 
guidelines (11). MIC was the lowest 
concentration of antibiotic at which there is no 
visible growth. 
Interpretations: In the statistical analysis MIC 
(or MBIC) values  at ≤ 1 µg/ml for  tobramycin 
or gentamicin, and ≤ 0.25 µg/ml for 
ciprofloxacin  were considered as 1 µg/ml and  
0.25 µg/ml respectively and which have MIC 
(or MBIC) values at ˃ 512 µg/ml  for  
tobramycin or gentamicin, and ˃ 128 µg/ml for 
ciprofloxacin  were considered as 1024 µg/ml 
and 256 µg/m respectively . The susceptible 
strains have tobramycin, gentamicin or 
ciprofloxacin MIC (or MBIC) values at ≤ 
4µg/ml, ≤ 4 µg/ml, and ≤ 1 µg/ml respectively  
and resistant strains have MIC (or MBIC) 
values at ≥ 8 µg/ml, ≥ 8 µg/ml, and ≥ 2 µg/ml 
respectively (13). 
Real- Time polymerase reaction: It was done 
to measure the expression of antibiotic 
resistance ndv B gene in 18 biofilm forming P. 
aerurginosa strains and their planktonic 
counterpart. Total bacterial RNA was isolated 
from the biofilm bacteria and planktonic 
counterpart. Briefly, the planktonic cells were 
cultivated in LB broth at 37°C to early 
stationary phase that corresponds to optical 
density of 0.7 at 600 nm , while the biofilm cells 
were grown on M63 agar plates overnight at 
37°C followed by another night at room 
temperature as described previously (14). RNA 
was extracted using IQeasy TM plus CTB RNA 
Extraction Mini Kit (iNtRON Biotechnology, 
Inc, Korea) according to manufacturer 
instructions. Reverse Transcription was done 
using Maxime RT PreMix Kit (iNtRON 
Biotechnology, Inc, Korea) in which 0.1 µg 
template RNA and distilled water were added 
into the Maxime RT PreMix tubes that contain 
random primer to a total volume of 20µl. 
Complementary DNA synthesis was 
performed at 45° C for 60 min and RTase 
inactivation step at 95 °C for 5 min, using PCR 
Thermal cycler (Biometra, Germany)  .  
Complementary DNA was measured with 
SYBR green real-time PCR using superReal 
premix plus kit (TIANGEN, China). To 
measure the ndvB gene expression, a pair of 
primers specific for ndvB gene (5′-GGCCTGAA 
CATCTTCTTCACC- 3′ [forward]) and (5′-
GATCTTGCCGACCTTGAAGAC -3′ [reverse]) 
was used to amplify and quantify cDNA 
corresponding to its mRNA. For a control, the 
primers (5′-GATCCGGAACAGGTGGAAGAC-
3′ [forward]) and (5′-TCAGCAGTTCC 
ACGGTACCC-3′ [reverse]) were used to 
amplify and quantify mRNA of the 
constitutively expressed bacterial rpoD gene 
(15). Each 20µl quantitative real-time PCR 
mixture contained 10µl SuperRealPreMix Plus, 
0.5 µl Rox dye , 100µM of  each primer and 2 µl 
cDNA (1µg cDNA)  . The cycler  (Stratagene 
Mx3000P qPCR real-time PCR) was 
programmed as following; 95 °C for 15 min, 
and 40 cycles each cycle consists of 95°C for 60 
sec., 56°C  for 30 sec. and 72° C for 30 sec.  
Statistical analysis: Continuous variables were 
expressed as the median (Range), and the 
categorical variables were expressed as a 
number (percentage). Paired data were 
analyzed using the Mann-Whitney U (MWU) 
test. Percent of categorical variables were 
compared using Chi-square test (χ2) with 
Fisher's exact correction. Spearman’s rank 
correlation coefficient (r) was calculated, (+) 
sign was indicator for direct relationship & (-) 
sign was indicator for inverse relationship. All 
tests were two sided, p-value <0.05 was 
considered significant. All statistics were 





During the study period, 92 p. aeruginosa 
isolates were identified from 274 clinical 
specimens. They were recovered from 24 
(33.3%) out of 72 wound exudates, 16 (44.4%) 
out of  36 burn exudate, 33 (29.5%) out of 112 
urine and 19 (35.2 %) out of  54 ETA specimens. 
44(47.8%) out of these 92 isolates were biofilm 
positive by tissue culture plate method. The 
biofilm formation was high among urine, ETA 
and burn isolates compared to isolates of 
wound specimens, however with statistically 
non-significant difference, P˃0.05 (Table 1). In 
urine specimens, 15  biofilm positive and 4 
biofilm negative P. aerruoginosa strains were 
isolated  from patients catheterized for more 
than 4 days, while 5 biofilm positive and 9 
negative were from paients catheterized for 
less than or equal to 4 days (p<  0.05)). In ETA , 
10 biofilm positive and 3 biofilm negative P. 
aerruoginosa strains were isolated from 
intubated patients  for more than 4 days, while 
1 biofilm positive and 5 negative were from 
ETA with intubation  of  less than or equal to 4 
days (p<  0.05) .  
After measuring MIC/ MBIC in µg /ml of the 
44 biofilm positive P. aeruginosa isolates and 
their planktonic counterpart to the 3 antibiotics, 
it was found that none of biofilm form were 
susceptible  to ciprofloxacin, tobramycin and 
gentamycin while 18 strains (40.9%), 12 strains 
(27.3%) and 13 strains (29.5%) of   the 
planktonic counterpart  were susceptible to the 
3 antibiotics respectively with high statistic 
significant differences between biofilm form 
and their planktonic counterpart , P<0.001 for 
each. The differences between median ( range ) 
of biofilm positive cells MBIC and those of 
their planktonic counterpart MIC for the 3 
antibiotics were statistically significant (Table 
2). .  
The expression of ndvB gene was measured  in 
18 biofilm isolates by SYBR green real time 
PCR It was higher among biofilm form in 
contrast to negligible expression in their 
planktonic counterpart and the difference 
between their median (range) of their 
expression was statistically significant (Table 
3). According to our findings of statistical 
analysis for  evaluating the association 
between the expression of ndvB gene and the 
antibiotic resistance  in biofilm forming 
isolates, there were significant correlations  
between ndvB  gene expression and MBIC 
values  of   ciprofloxacin  (r=+ 0.65, P< 0.001), 
tobramycin ( r= + 0.54 ,P<  0.05) and 
gentamycin (r=+ 0.77 ,P< 0.001). 
 









 Biofilm positive 
(N=44) 
 
No. % No. % 
Wound 24 17 70.8%  7 29.2%  
Urine 33 13 39.4%  20 60.6%  
ETA 19 8 42.1%  11 57.9%  
Burn 16 10 62.5%  6 37.5%  
χ2  6.96  
*p-value  0.073  
Qualitative data are presented as number (%),χ2: Chi-square  test, *p 0.05 is non-significant. 
 
 
TABLE (2): COMPARISON BETWEEN PLANKTONIC BIOFILM +VE MIC AND BIOFILM +VE MBIC OF 










Median (Range) Median (Range) Z #p-value 
Ciprofloxacin  16 (0.25 – 128)  96 (32 – 256)  -5.92 <0.001 
Tobramycin  96 (1.0 – 512)  512 (64 – 1024)  -4.80 <0.001 
Gentamycin  128 (1.0 – 1024)  512 (8 – 1024)  -4.14 <0.001 




TABLE (3): RELATIVE EXPRESSION OF  NDVB GENE IN RELATION TO CONTROL GENE IN  BIOFILM +VE 
ISOLATES AND PLANKTONIC COUNTERPARTS 
 
 
 Planktonic  
(N=18) 
 Biofilm +ve  
(N=18) 
 *MWU test  
Median (Range) Median (Range) Z #p-value 
Relative 
cDNA conc. 
 0.0008 (0.0006 – 0.0329)  5.1060 (2.0110 – 7.4370)  -5.11 <0.001 
*MWU: Mann-Whitney U Test; #p< 0.001 is  highly significant. 
 
DISCUSSION                                                                                                                      
Our finding that 47.8% of  isolated P. aeruginosa 
strains were biofilm positive is in consistent 
with Hassan et al (16) and contrasting with  
Gupta et al (17) who found that all P. aeruginosa 
isolates were biofilm producers.                            
In our study, biofilm production was 29.2% 
from wound, 37.5%from burn, 60.6% from 
urine and 57.9% from ETA specimens . We 
didn't find any statistically significant 
differences in biofilm production among the P. 
aeruginosa strains recovered from different 
specimens,  which comes in agreement with the 
result of Mikucionyte et al (18). 
However, different clinical results were 
reported by different authors. It was100% or 
95% among isolates from ETAs in ICUs (19,20), 
76.4% among urine isolates of catheterized 
patients (21)and  40% or 60 % among chronic 
infected wound isolates  (22,23). 
Microorganisms must adhere to exposed 
surfaces of devices for long period to be 
irreversibly attached, once irreversibly 
attached, it produce extracellular 
polysaccharide matrix to develop a biofilm 
(24). In our study, instrumentation either by 
urinary catheter or endotracheal tube for more 
than 4 days considered as risk factor as it 
increased the risk for acquiring biofilm 
formation than in instrumented patients less 
than 4 days, which agrees with many reports 
from different studies (24-26).  
None of 44 biofilm cells were susceptible to 
ciprofloxacin, tobramycin and gentamycin 
while 18, 12 and 13 strains of   the planktonic 
counterparts were susceptible to the 3 
antibiotic respectively. This result is more or 
less in agreement with a previous study carried 
out in ICU of Zagazig University Hospitals 
(27). In the same direction, Sepandj et al (28) 
found that, out of 8 strains, by using MIC 
results 8, 6 and 7 isolates were sensitive to 
ciprofloxacin, tobramycin and gentamycin 
respectively while, by measuring minimal 
biofilm eliminating concentration ( MBEC), 
they found that sensitive isolates were one for 
each antibiotic. 
In previous studies, several P.aeruginosa genes 
were identified that contribute to biofilm-
specific antibiotic resistance by screening for 
mutants with increased antibiotic sensitivity 
when growing in biofilms (6,29,30). One of 
These genes, ndvB, encodes a 
glucosyltransferase enzyme involved in the 
formation of cyclic glucans (6).  
In our study, the expression of ndvB gene was 
significantly higher among biofilm +ve P. 
aeruginosa isolates than their planktonic 
counterparts. There were also significant 
correlations between the gene expression and 
MBIC values of   ciprofloxacin, tobramycin and 
gentamycin .These results are in consistent 
with the results reported on mutants of P. 
aeruginosa growing in biofilm  (6,7,15) where 
Mah et al (6) reported that  biofilm form of  P. 
aeruginosa PA 14 had increased antibiotic  
resistance especially to the antibiotic  
tobramycin, compared to the isogenic ndvB 
mutant.  Those authors proposed that this 
resistance was due to the ability of  crude 
periplasmic carbohydrate  extracts to interact 
physically with tobramycin forming molecular 
complex and prevent antibiotic from reaching 
to its site of action. The proposed mechanism is 
in agreement with the known properties of 
cyclodextrins, cyclic glucans derived from 
starch, as good chelating agents forming 
inclusion complexes with a wide variety of 
hydrophobic guest molecules (31) . 
Furthermore, other studies have reported 
increased sensitivity of double mutant 
ndvB/pa1874-1877 and ndv B/PA0756-0757 to 
gentamycin and  tobramycin (1,29). The 
relation between increased ndvB gene 
expression and synthesis of glucans in 
planktonic and biofilm cells have been studied 
by direct chemical analysis (7), and it was  
found that total amount of glucans was higher  
in biofilm culture which was in agreement with 
up-regulation of ndvB gene expression. The 
chemical structure of ndvB – dependent P. 
aeruginosa glucans was identified and it was 
able to interact with the aminoglycoside 
kanamycin, most probably by forming 
molecular complexes stabilized by ionic 
interaction. Importantly the cyclic nature and 
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the high negative charge of the cyclic B-(1...3)-
glucans is in a good agreement with their 
properties to bind to positively charged 
antibiotics (7). 
Conclusion: P. aeruginosais has the ability to 
form biofilm that is the a cause of antibiotic 
resistance. Increasesd NdvB gene expression is 
an important mechanism of resistance in P. 
aeruginosa biofilm , and increased MBIC of 
biofilm positive P. aeruginosa isolates to 
ciprofloxacin , tobramycin and gentamycin  was 
associated with increased expression of this gene. 
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